Quarterly report · Q2
2269.TEDINET S100PI81
Period2022-04-01 → 2022-09-30
Filed2022-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥517.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥1.01T | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥500.7bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥43.2bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥50.3bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥43.9bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥94.0bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥51.8bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥48.3bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥55.2bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥33.4bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥87.5bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥36.6bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥34.9bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥40.0bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥1.18T | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥1.12T | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥1.14T | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥426.8bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥404.4bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥757.0bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥713.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥695.7bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥92.1bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥67.4bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥88.7bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥64.9bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥80.9bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥39.0bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥25.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥127.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥61.2bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥26.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥27.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥35.6bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥20.3bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥77.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥14.6bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥237.04 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥123.31 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥607.24 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥252.54 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥166.44 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 60.6% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.3% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.4% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥292m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥292m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥786m |
| jpcrp040300-q2r_E21902-000Foodreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥420.6bn |
| jpcrp040300-q2r_E21902-000Foodreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥420.4bn |
| jpcrp040300-q2r_E21902-000Foodreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥278m |
| jpcrp040300-q2r_E21902-000Foodreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥29.3bn |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥97.2bn |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥97.2bn |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥13m |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥14.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥517.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥517.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥292m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥44.0bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥468m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥468m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥534m |
| jpcrp040300-q2r_E21902-000Foodreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥409.1bn |
| jpcrp040300-q2r_E21902-000Foodreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥408.8bn |
| jpcrp040300-q2r_E21902-000Foodreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥254m |
| jpcrp040300-q2r_E21902-000Foodreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥39.6bn |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥92.1bn |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥91.9bn |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥214m |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥11.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥501.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥500.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥468m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥50.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 561
| Item | Context | Value | Unit |
|---|---|---|---|
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 46256000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 55704000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 3380000000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 1618000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 55241000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 48303000000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 24577000000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 26192000000 | JPY |
| Impairment loss ope cf | Prior1YTDDuration | 517000000 | JPY |
| Impairment loss ope cf | CurrentYTDDuration | 239000000 | JPY |
| Amortization of goodwill ope cf | Prior1YTDDuration | 7000000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 7000000 | JPY |
| Loss on retirement of property plant and equipment ope cf | Prior1YTDDuration | 1262000000 | JPY |
| Loss on retirement of property plant and equipment ope cf | CurrentYTDDuration | 1554000000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | -8000000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | -15000000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | -1040000000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | -1006000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YTDDuration | 1850000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYTDDuration | 2141000000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -842000000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -951000000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 254000000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 241000000 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YTDDuration | -1709000000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYTDDuration | -628000000 | JPY |
| Loss gain on sales of property plant and equipment ope cf | Prior1YTDDuration | -1488000000 | JPY |
| Loss gain on sales of property plant and equipment ope cf | CurrentYTDDuration | -5460000000 | JPY |
| Loss gain on sales of stocks of subsidiaries and affiliates ope cf | Prior1YTDDuration | -2394000000 | JPY |
| Loss gain on sales of stocks of subsidiaries and affiliates ope cf | CurrentYTDDuration | -1068000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -8112000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -17188000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -3882000000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -14405000000 | JPY |
| Increase or decrease of contract liability ope cf | Prior1YTDDuration | 11836000000 | JPY |
| Increase or decrease of contract liability ope cf | CurrentYTDDuration | -3500000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | -5130000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 725000000 | JPY |
| Other net ope cf | Prior1YTDDuration | 9120000000 | JPY |
| Other net ope cf | CurrentYTDDuration | 4448000000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 80058000000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 39627000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 1556000000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 2022000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -270000000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -246000000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -20158000000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -16242000000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 61186000000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 25160000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |